TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.1487
+0.0036 (2.48%)
Nov 17, 2026, 10:21 AM EST - Market open
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $10.08 million as of November 17, 2026. It is the 41,369th most valuable company in the world and the 5,538th biggest in the United States. Its market cap has decreased by 83.85% in one year.
Market Cap
10.08M
Enterprise Value
26.32M
1-Year Change
-83.85%
Global Rank
Country Rank
#5,538 United States
Category
ChartMarket Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $10.08M, a decrease of -97.19%. That is a compound annual growth rate of -48.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 10.08M | -82.24% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 11.36M |
| Vyome Holdings | 11.09M |
| Aligos Therapeutics | 10.84M |
| Palatin Technologies | 10.76M |
| Purple Biotech | 10.61M |
| Cellectar Biosciences | 10.37M |
| Lisata Therapeutics | 10.36M |
| Intensity Therapeutics | 10.17M |